PGNY SEC Filing News — Progyny, Inc.

Latest SEC filings for Progyny, Inc. (PGNY) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-16.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed d…
Sector: Healthcare Industry: Healthcare Plans Market Cap: $2.1B CIK: 1551306
20
Total Filings
0
Bullish Classifications
6
Bearish Classifications
14
Insider Transactions
1
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for PGNY currently lean bearish. Of the 20 filing records displayed, 6 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
PGNY Filing Activity Snapshot 2026-06-05 — 2026-10-16
Insider Transactions (Form 4)
0 buys vs 6 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$321.4K
GORDON KEVIN K (Director) · 2026-09-14
11,500 shares · Form 4
Form 144 Notices
4
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 14 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 14 filings in this group are Form 4s for Progyny, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 14 insider filings shown, the breakdown is 8 tax withholding and 6 open-market sale. 6 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Tax withholding ×8
Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.
Open-market sale ×6
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Form 4 Open-market sale Insider Selling 2026-10-16

PGNY insider Cummings Melissa B (Chief Operating Officer) sold 1,879 shares (~$52.6K)

Cummings Melissa B, listed as Chief Operating Officer at Progyny, Inc., reported an open-market sale of 1,879 PGNY shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 1,559 $27.39 $42.7K
S Open-market sale 1,879 $28.00 $52.6K
Filing: Form 4 (Insider Transaction) Insider: Cummings Melissa B (Chief Operating Officer) Shares: 1,879 Est. Value: $52.6K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-28

PGNY insider Swartz Allison (EVP, GC) sold 3,903 shares (~$101.9K)

Swartz Allison, listed as EVP, GC at Progyny, Inc., reported an open-market sale of 3,903 PGNY shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,903 $26.10 $101.9K
Filing: Form 4 (Insider Transaction) Insider: Swartz Allison (EVP, GC) Shares: 3,903 Est. Value: $101.9K
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-09-21

PGNY insider Form 4 filed for equity award, exercise, or tax withholding

Clapp Geoffrey (Chief Product Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 819 $27.38 $22.4K
Filing: Form 4 (Insider Transaction) Insider: Clapp Geoffrey (Chief Product Officer) Shares: 819
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-14

PGNY insider GORDON KEVIN K (Director) sold 11,500 shares (~$321.4K)

GORDON KEVIN K, listed as Director at Progyny, Inc., reported an open-market sale of 11,500 PGNY shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 22,000 $13.00 $286.0K
F Tax withholding on vested shares 10,500 $27.24 $286.0K
S Open-market sale 11,500 $27.94 $321.4K
M Option exercise derivative · Stock Option (Right to Buy) 22,000 — —
Filing: Form 4 (Insider Transaction) Insider: GORDON KEVIN K (Director) Shares: 11,500 Est. Value: $321.4K
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-09-08

PGNY insider Form 4 filed for equity award, exercise, or tax withholding

Anevski Peter (Director, CHIEF EXECUTIVE OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 5,361 $26.29 $140.9K
Filing: Form 4 (Insider Transaction) Insider: Anevski Peter (Director, CHIEF EXECUTIVE OFFICER) Shares: 5,361
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-09-08

PGNY insider Form 4 filed for equity award, exercise, or tax withholding

Swartz Allison (EVP, GC) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 828 $26.29 $21.8K
F Tax withholding on vested shares 479 $26.61 $12.7K
Filing: Form 4 (Insider Transaction) Insider: Swartz Allison (EVP, GC) Shares: 1,307
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-09-08

PGNY insider Form 4 filed for equity award, exercise, or tax withholding

Livingston Mark S. (CHIEF FINANCIAL OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 479 $26.61 $12.7K
Filing: Form 4 (Insider Transaction) Insider: Livingston Mark S. (CHIEF FINANCIAL OFFICER) Shares: 479
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-09-04

PGNY insider Form 4 filed for equity award, exercise, or tax withholding

Livingston Mark S. (CHIEF FINANCIAL OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 224 $25.66 $5.7K
F Tax withholding on vested shares 1,532 $26.29 $40.3K
Filing: Form 4 (Insider Transaction) Insider: Livingston Mark S. (CHIEF FINANCIAL OFFICER) Shares: 1,756
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-09-01

PGNY insider Form 4 filed for equity award, exercise, or tax withholding

Swartz Allison (EVP, GC) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 1,352 $25.86 $35.0K
Filing: Form 4 (Insider Transaction) Insider: Swartz Allison (EVP, GC) Shares: 1,352
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-07-16

PGNY insider Cummings Melissa B (Chief Operating Officer) sold 2,244 shares (~$70.9K)

Cummings Melissa B, listed as Chief Operating Officer at Progyny, Inc., reported an open-market sale of 2,244 PGNY shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 1,193 $31.98 $38.2K
S Open-market sale 2,244 $31.60 $70.9K
Filing: Form 4 (Insider Transaction) Insider: Cummings Melissa B (Chief Operating Officer) Shares: 2,244 Est. Value: $70.9K
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-06-23

PGNY insider Form 4 filed for equity award, exercise, or tax withholding

Clapp Geoffrey (Chief Product Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 819 $26.60 $21.8K
Filing: Form 4 (Insider Transaction) Insider: Clapp Geoffrey (Chief Product Officer) Shares: 819
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-06-05

PGNY insider Livingston Mark S. (CHIEF FINANCIAL OFFICER) sold 2,517 shares (~$64.2K)

Livingston Mark S., listed as CHIEF FINANCIAL OFFICER at Progyny, Inc., reported an open-market sale of 2,517 PGNY shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 1,082 $25.12 $27.2K
F Tax withholding on vested shares 339 $24.99 $8.5K
S Open-market sale 1,918 $25.50 $48.9K
S Open-market sale 599 $25.50 $15.3K
Filing: Form 4 (Insider Transaction) Insider: Livingston Mark S. (CHIEF FINANCIAL OFFICER) Shares: 2,517 Est. Value: $64.2K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-06-05

PGNY insider Swartz Allison (EVP, GC) sold 1,798 shares (~$45.0K)

Swartz Allison, listed as EVP, GC at Progyny, Inc., reported an open-market sale of 1,798 PGNY shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 676 $25.12 $17.0K
S Open-market sale 1,199 $25.02 $30.0K
F Tax withholding on vested shares 339 $24.99 $8.5K
S Open-market sale 599 $25.08 $15.0K
Filing: Form 4 (Insider Transaction) Insider: Swartz Allison (EVP, GC) Shares: 1,798 Est. Value: $45.0K
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-06-05

PGNY insider Form 4 filed for equity award, exercise, or tax withholding

Anevski Peter (Director, CHIEF EXECUTIVE OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 5,361 $25.12 $134.7K
Filing: Form 4 (Insider Transaction) Insider: Anevski Peter (Director, CHIEF EXECUTIVE OFFICER) Shares: 5,361
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 4 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Progyny, Inc. has 4 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-10-14

PGNY Form 144 filed for proposed insider sale by Cummings Melissa B (1,879 shares) ~$52.6K

Cummings Melissa B filed a Form 144 with the SEC indicating intent to sell PGNY (Progyny, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Cummings Melissa B Shares: 1,879 Est. Value: $52.6K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-23

PGNY Form 144 filed for proposed insider sale by Swartz Allison (3,903 shares) ~$101.9K

Swartz Allison filed a Form 144 with the SEC indicating intent to sell PGNY (Progyny, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Swartz Allison Shares: 3,903 Est. Value: $101.9K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-10

PGNY Form 144 filed for proposed insider sale by GORDON KEVIN K (11,500 shares) ~$311.9K

GORDON KEVIN K filed a Form 144 with the SEC indicating intent to sell PGNY (Progyny, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: GORDON KEVIN K Shares: 11,500 Est. Value: $311.9K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-07-14

PGNY Form 144 filed for proposed insider sale by Cummings Melissa B (2,244 shares) ~$70.9K

Cummings Melissa B filed a Form 144 with the SEC indicating intent to sell PGNY (Progyny, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Cummings Melissa B Shares: 2,244 Est. Value: $70.9K
View on SEC EDGAR → Open Filing Document →
Material Events 1 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There is 1 in this period for Progyny, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-08-06

PGNY filed 8-K — material company event

Progyny, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for Progyny, Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-07

PGNY filed Quarterly Report (10-Q)

Progyny, Inc. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)
View on SEC EDGAR → Open Filing Document →

How we classify Progyny, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on PGNY. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — PGNY SEC Filings

More Tools for PGNY

PGNY Full Stock Analysis PGNY Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper PGNY analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the PGNY stock analysis page.

PGNY Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer